02/01/12 - Sophia-Antipolis, France

MEDIAN signe un contrat majeur avec Sanofi

MEDIAN Technologies signe un contrat majeur avec le laboratoire SANOFI pour l’interprétation et la gestion des images dans une nouvelle étude de phase II sur le cancer du poumon à petites cellules.

 

02/01/12 - Sophia-Antipolis, France

MEDIAN has signed a landmark contract with Sanofi

MEDIAN Technologies has signed a landmark contract with the top pharmaceutical company SANOFI for medical image interpretation and management in a new phase II study on small cells lung cancer.

 
 
/ Home
/ Target Audience

Patients

Target Audience - Patients

Cancer patients need the highest level of quality of health care.

  • LMS provides repeatable and objective measurement of lesion growth.
  • LMS automatically checks for new lung metastases for more accurate and earlier staging.


Cancer patients need to rely upon good and efficient communication among all specialists involved in their care.

  • LMS provides a standardized oncology imaging report for use during tumor boards.
  • LMS automatically generates reports according to RECIST criteria for patients involved in clinical trials.

 

It is quite common for patients to have their cancer diagnosed and staged at one hospital and then be followed-up at another.

  • LMS provides unique multi-site integration capabilities with centralized data management.
  • LMS centralized data management system makes all the lesion information obtained during the initial evaluation and staging available for follow-up.